Sedation Versus No Sedation for Detection Rates of Precancerous Lesions and Cancer

Early Detection of Cancer Clinical Trial

Official title:

Sedation Versus No Sedation for Diagnostic Esophagogastroduodenoscopies and Detection Rates of Precancerous Lesions and Cancer: a Case-control Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04069975
• Other study ID #: 2019SDU-QILU-09
• Status: Recruiting
• Start date: June 2, 2019
• Est. completion date: June 2020

Study information

• Verified date: August 2019
• Source: Shandong University
• Contact: Yanqing LI, Doctor
• Phone: 13573106261
• Email: liyanqing[@]sdu.edu.cn
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The influence of sedation on the endoscopic detection rate of the precancerous lesions and cancer of upper digestive system has not been assessed. In the daily medical routine of China, patients have the right to choose the sedation style according to his or her own situation, whose detailed endoscopic data of patients are recorded in the endoscopy quality control system. The aim of this research is to detect whether the use of sedation can help improve detection rate of precancerous lesions and cancer of upper digestive system.

Description:

The influence of sedation on the endoscopic detection rate of the precancerous lesions and cancer of upper digestive system has not been assessed. In the daily medical routine of China, patients have the right to choose the sedation style according to his or her own situation, whose detailed endoscopic data of patients are recorded in the endoscopy quality control system. The aim of this research is to detect whether the use of sedation can help improve detection rate of precancerous lesions and cancer of upper digestive system.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200000
• Est. completion date: June 2020
• Est. primary completion date: June 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients aged more than 18 years with or without GI symptoms attending for endoscopy from 2012 to 2019.

Exclusion Criteria:

• Patients unable to cooperated the endoscopy or unable to complete it. People with endoscopy contraindications are naturally excluded.

Related Conditions & MeSH terms

• Early Detection of Cancer

Intervention

Other:
• Sedation
The group of patients who did endoscopies with or without sedation. (This is a choice of themselves)

Locations

Country	Name	City	State
China	Department of Gastroenterology, Qilu Hospital, Shandong University	Jinan	Shandong

Sponsors (4)

Lead Sponsor	Collaborator
Shandong University	Binzhou Medical University, Qilu Hospital of Shandong University (Qingdao), Weihai Municipal Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Detection rate of precancerous lesions and cancer of upper digestive system improvement	Detection rate of precancerous lesions and cancer of upper digestive system improvement	2020